RJFSA
PLXP

Raymond James Financial Services Advisors’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Raymond James Financial Services Advisors’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,650
Closed -$17K – 2590
2017
Q1 		$17K Buy
1,650
+375
+29% +$4.08K ﹤0.01% 2386
2016
Q4 		$16K Sell
1,275
-170
-12% -$6.25K ﹤0.01% 2307
2016
Q3 		$168K Buy
+1,445
New +$141K ﹤0.01% 2080

Other funds holding PLXP

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
HWA
Heritage Way Advisors Rockford, Illinois $267M AUM 23.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Raymond James Financial Services Advisors's PLXP Position: Q2 2017 in Review

Raymond James Financial Services Advisors sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2017, closing a stake of 1,650 shares — an estimated $17K sold.

Raymond James Financial Services Advisors first reported a position in PLXP in Q3 2016 and held it in 3 quarters. The position peaked at $168K in Q3 2016. 14 funds tracked by Wall St. Rank hold PLXP as of Q2 2017.

  • Raymond James Financial Services Advisors reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 1,650 PLx Pharma Inc. Common Stock shares in Q2 2017, an estimated $17K.
  • Raymond James Financial Services Advisors first reported a position in PLx Pharma Inc. Common Stock in Q3 2016 and held it in 3 quarters.
  • Raymond James Financial Services Advisors's PLx Pharma Inc. Common Stock position peaked at $168K in Q3 2016.
  • 14 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2017.

Based on Raymond James Financial Services Advisors's 13F filing for Q2 2017, filed 15 Aug 2017.